These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of PFKFB3-driven glycolysis in vessel sprouting. De Bock K; Georgiadou M; Schoors S; Kuchnio A; Wong BW; Cantelmo AR; Quaegebeur A; Ghesquière B; Cauwenberghs S; Eelen G; Phng LK; Betz I; Tembuyser B; Brepoels K; Welti J; Geudens I; Segura I; Cruys B; Bifari F; Decimo I; Blanco R; Wyns S; Vangindertael J; Rocha S; Collins RT; Munck S; Daelemans D; Imamura H; Devlieger R; Rider M; Van Veldhoven PP; Schuit F; Bartrons R; Hofkens J; Fraisl P; Telang S; Deberardinis RJ; Schoonjans L; Vinckier S; Chesney J; Gerhardt H; Dewerchin M; Carmeliet P Cell; 2013 Aug; 154(3):651-63. PubMed ID: 23911327 [TBL] [Abstract][Full Text] [Related]
3. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Schoors S; De Bock K; Cantelmo AR; Georgiadou M; Ghesquière B; Cauwenberghs S; Kuchnio A; Wong BW; Quaegebeur A; Goveia J; Bifari F; Wang X; Blanco R; Tembuyser B; Cornelissen I; Bouché A; Vinckier S; Diaz-Moralli S; Gerhardt H; Telang S; Cascante M; Chesney J; Dewerchin M; Carmeliet P Cell Metab; 2014 Jan; 19(1):37-48. PubMed ID: 24332967 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting. Vandekeere S; Dewerchin M; Carmeliet P Microcirculation; 2015 Oct; 22(7):509-17. PubMed ID: 26250801 [TBL] [Abstract][Full Text] [Related]
6. Control of vessel sprouting by genetic and metabolic determinants. Eelen G; Cruys B; Welti J; De Bock K; Carmeliet P Trends Endocrinol Metab; 2013 Dec; 24(12):589-96. PubMed ID: 24075830 [TBL] [Abstract][Full Text] [Related]
7. The role of glycolysis and mitochondrial respiration in the formation and functioning of endothelial tip cells during angiogenesis. Yetkin-Arik B; Vogels IMC; Nowak-Sliwinska P; Weiss A; Houtkooper RH; Van Noorden CJF; Klaassen I; Schlingemann RO Sci Rep; 2019 Aug; 9(1):12608. PubMed ID: 31471554 [TBL] [Abstract][Full Text] [Related]
8. Incomplete and transitory decrease of glycolysis: a new paradigm for anti-angiogenic therapy? Schoors S; Cantelmo AR; Georgiadou M; Stapor P; Wang X; Quaegebeur A; Cauwenberghs S; Wong BW; Bifari F; Decimo I; Schoonjans L; De Bock K; Dewerchin M; Carmeliet P Cell Cycle; 2014; 13(1):16-22. PubMed ID: 24335389 [TBL] [Abstract][Full Text] [Related]
9. A Vascular Endothelial Growth Factor-Dependent Sprouting Angiogenesis Assay Based on an In Vitro Human Blood Vessel Model for the Study of Anti-Angiogenic Drugs. Pauty J; Usuba R; Cheng IG; Hespel L; Takahashi H; Kato K; Kobayashi M; Nakajima H; Lee E; Yger F; Soncin F; Matsunaga YT EBioMedicine; 2018 Jan; 27():225-236. PubMed ID: 29289530 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy. Cantelmo AR; Conradi LC; Brajic A; Goveia J; Kalucka J; Pircher A; Chaturvedi P; Hol J; Thienpont B; Teuwen LA; Schoors S; Boeckx B; Vriens J; Kuchnio A; Veys K; Cruys B; Finotto L; Treps L; Stav-Noraas TE; Bifari F; Stapor P; Decimo I; Kampen K; De Bock K; Haraldsen G; Schoonjans L; Rabelink T; Eelen G; Ghesquière B; Rehman J; Lambrechts D; Malik AB; Dewerchin M; Carmeliet P Cancer Cell; 2016 Dec; 30(6):968-985. PubMed ID: 27866851 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis revisited - role and therapeutic potential of targeting endothelial metabolism. Stapor P; Wang X; Goveia J; Moens S; Carmeliet P J Cell Sci; 2014 Oct; 127(Pt 20):4331-41. PubMed ID: 25179598 [TBL] [Abstract][Full Text] [Related]
13. The Glycolytic Enzyme PFKFB3 Is Involved in Estrogen-Mediated Angiogenesis via GPER1. Trenti A; Tedesco S; Boscaro C; Ferri N; Cignarella A; Trevisi L; Bolego C J Pharmacol Exp Ther; 2017 Jun; 361(3):398-407. PubMed ID: 28348059 [TBL] [Abstract][Full Text] [Related]
14. Endothelial Metabolism Driving Angiogenesis: Emerging Concepts and Principles. Cantelmo AR; Brajic A; Carmeliet P Cancer J; 2015; 21(4):244-9. PubMed ID: 26222074 [TBL] [Abstract][Full Text] [Related]
15. The PFKFB3 Inhibitor AZ67 Inhibits Angiogenesis Independently of Glycolysis Inhibition. Emini Veseli B; Van Wielendaele P; Delibegovic M; Martinet W; De Meyer GRY Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073144 [TBL] [Abstract][Full Text] [Related]
16. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3). Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030 [TBL] [Abstract][Full Text] [Related]
17. Laminar shear stress inhibits endothelial cell metabolism via KLF2-mediated repression of PFKFB3. Doddaballapur A; Michalik KM; Manavski Y; Lucas T; Houtkooper RH; You X; Chen W; Zeiher AM; Potente M; Dimmeler S; Boon RA Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):137-45. PubMed ID: 25359860 [TBL] [Abstract][Full Text] [Related]
18. Intermedin restricts vessel sprouting by inhibiting the loosening of endothelial junction. Xiao F; Wang LJ; Zhao H; Tan C; Wang DN; Zhang H; Wei YG; Liu J; Zhang W Biochem Biophys Res Commun; 2015 Feb; 458(1):174-9. PubMed ID: 25637664 [TBL] [Abstract][Full Text] [Related]
19. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Bentley K; Franco CA; Philippides A; Blanco R; Dierkes M; Gebala V; Stanchi F; Jones M; Aspalter IM; Cagna G; Weström S; Claesson-Welsh L; Vestweber D; Gerhardt H Nat Cell Biol; 2014 Apr; 16(4):309-21. PubMed ID: 24658686 [TBL] [Abstract][Full Text] [Related]
20. YAP promotes ocular neovascularization by modifying PFKFB3-driven endothelial glycolysis. Feng Y; Zou R; Zhang X; Shen M; Chen X; Wang J; Niu W; Yuan Y; Yuan F Angiogenesis; 2021 Aug; 24(3):489-504. PubMed ID: 33400016 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]